Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by robertshawon Dec 16, 2021 9:07am
658 Views
Post# 34236090

RE:RE:RE:RE:RE:RE:RE:Q about BTD

RE:RE:RE:RE:RE:RE:RE:Q about BTD
robertshaw wrote:
Infinity wrote: I agree with Enrique,  we are close to submiting the application for Break through designation.  I tried to gather some info from the FDA web page re BTD application process.  Appears straightforward.  The qualifer would be a significant "UNMET Demand" should exist for this type of cure or treatment.  I believe TLT would meet this criteria of unmet demand and the efficacy is already proven, except that we need to wait for a few more patients to cross over from Pending to  Partial and Complete recovery.  
I for one am going to  take a break and sit tight for now and not worry about stock price fluctuations.  I expect by Spring 2022 we should be well on our way to be proven winner and may even reach a point by Summer of 2022 that we will no longer be a Penny stock!!.  The major move will come when TLT trading volume goes up and gets listed in the TSX instead of the Venture exchange..

Agree with Infiity.
It's in fact the great honor of FDA to grant BTD to us....ASAP ( I amexpecting before Next May).

Otherwise I see no difference betwween FDA and our old friends--Blowjobjoe's bosses.


No other medical treatment technology in human history could  ever achieve the height of TLD1433. 
It's also "great hornor" of  blojobjoe's bosses that almost beated this brilliant technology to death... but, anyway, we survived. So, it's quite safe to say now"Blowjobjoe's bosses '  days are numbered..."

<< Previous
Bullboard Posts
Next >>